The NIHR Clinical Research Network has announced that it reached a milestone in study set up achievements by recruiting 25 first global patients in commercial studies in the 2013/14 financial year.
The 25th study to make this highly sought after achievement was at Manchester Royal Eye Hospital, a site of the Central Manchester University Hospitals NHS Foundation Trust. It aims to build on existing safety and effectiveness data for ocriplasmin, a treatment for some people with the rare eye condition, vitreomacular traction.
Recruiting a first global patient is a key performance indicator for the life-sciences industry in clinical research delivery as it shows the Network can support the rapid set-up of studies.
Since the Network started to record first global patients, it has achieved 42 in total. But it is during the past financial year that it has seen a rapid upturn in the number of studies to make the achievement. This is down to the reduction of study set-up times.